These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


779 related items for PubMed ID: 20101232

  • 1. ERalpha signaling through slug regulates E-cadherin and EMT.
    Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH.
    Oncogene; 2010 Mar 11; 29(10):1451-62. PubMed ID: 20101232
    [Abstract] [Full Text] [Related]

  • 2. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug 11; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Involvement of Pin1 induction in epithelial-mesenchymal transition of tamoxifen-resistant breast cancer cells.
    Kim MR, Choi HK, Cho KB, Kim HS, Kang KW.
    Cancer Sci; 2009 Oct 11; 100(10):1834-41. PubMed ID: 19681904
    [Abstract] [Full Text] [Related]

  • 5. Oncofetal H19 RNA promotes tumor metastasis.
    Matouk IJ, Raveh E, Abu-lail R, Mezan S, Gilon M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M, Richler C, Fellig Y, Sorin V, Hubert A, Hochberg A, Czerniak A.
    Biochim Biophys Acta; 2014 Jul 11; 1843(7):1414-26. PubMed ID: 24703882
    [Abstract] [Full Text] [Related]

  • 6. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K, Zeng J, Zhou J, Fan J, Chen Y, Wang Z, Zhang T, Wang X, He D.
    Urol Oncol; 2013 Nov 11; 31(8):1751-60. PubMed ID: 22421353
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
    Shah P, Gau Y, Sabnis G.
    Breast Cancer Res Treat; 2014 Jan 11; 143(1):99-111. PubMed ID: 24305977
    [Abstract] [Full Text] [Related]

  • 8. ERalpha suppresses slug expression directly by transcriptional repression.
    Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Barsky SH.
    Biochem J; 2008 Dec 01; 416(2):179-87. PubMed ID: 18588516
    [Abstract] [Full Text] [Related]

  • 9. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
    Zheng H, Li W, Wang Y, Liu Z, Cai Y, Xie T, Shi M, Wang Z, Jiang B.
    Eur J Cancer; 2013 Aug 01; 49(12):2734-46. PubMed ID: 23582741
    [Abstract] [Full Text] [Related]

  • 10. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.
    Park SH, Cheung LW, Wong AS, Leung PC.
    Mol Endocrinol; 2008 Sep 01; 22(9):2085-98. PubMed ID: 18550773
    [Abstract] [Full Text] [Related]

  • 11. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ, Han HJ.
    Am J Physiol Renal Physiol; 2010 May 01; 298(5):F1263-75. PubMed ID: 20015942
    [Abstract] [Full Text] [Related]

  • 12. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells.
    Belguise K, Guo S, Sonenshein GE.
    Cancer Res; 2007 Jun 15; 67(12):5763-70. PubMed ID: 17575143
    [Abstract] [Full Text] [Related]

  • 13. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, Wang Y, Gu S, Zhao X.
    Mol Cancer; 2015 Feb 03; 14(1):28. PubMed ID: 25645291
    [Abstract] [Full Text] [Related]

  • 14. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y, Feng X, Zheng L, Li SL, Ge XY, Zhang JG.
    Oncotarget; 2015 Sep 22; 6(28):25506-19. PubMed ID: 26325518
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of epithelial to mesenchymal transition in metastatic breast carcinoma cells by c-Src suppression.
    Liu X, Feng R.
    Acta Biochim Biophys Sin (Shanghai); 2010 Jul 22; 42(7):496-501. PubMed ID: 20705589
    [Abstract] [Full Text] [Related]

  • 16. Identification of a GαGβγ, AKT and PKCα signalome associated with invasive growth in two genetic models of human breast cancer cell epithelial-to-mesenchymal transition.
    Ouelaa-Benslama R, De Wever O, Hendrix A, Sabbah M, Lambein K, Land D, Prévost G, Bracke M, Hung MC, Larsen AK, Emami S, Gespach C.
    Int J Oncol; 2012 Jul 22; 41(1):189-200. PubMed ID: 22552300
    [Abstract] [Full Text] [Related]

  • 17. P-cadherin induces an epithelial-like phenotype in oral squamous cell carcinoma by GSK-3beta-mediated Snail phosphorylation.
    Bauer K, Dowejko A, Bosserhoff AK, Reichert TE, Bauer RJ.
    Carcinogenesis; 2009 Oct 22; 30(10):1781-8. PubMed ID: 19654099
    [Abstract] [Full Text] [Related]

  • 18. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T, Nyarko JN, Kuski K, Fehr K, Pennington PR, Truitt L, Freywald A, Lukong KE, Anderson DH, Mousseau DD.
    Cell Signal; 2014 Dec 22; 26(12):2621-32. PubMed ID: 25152370
    [Abstract] [Full Text] [Related]

  • 19. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N, Tichet M, Dufies M, Pottier A, Mogha A, Soo JK, Rocchi S, Mallavialle A, Galibert MD, Khammari A, Lacour JP, Ballotti R, Deckert M, Tartare-Deckert S.
    PLoS One; 2012 Dec 22; 7(7):e40378. PubMed ID: 22911700
    [Abstract] [Full Text] [Related]

  • 20. AIB1 cooperates with ERα to promote epithelial mesenchymal transition in breast cancer through SNAI1 activation.
    Wang M, Zhao F, Li S, Chang AK, Jia Z, Chen Y, Xu F, Pan H, Wu H.
    PLoS One; 2013 Dec 22; 8(6):e65556. PubMed ID: 23762395
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 39.